Skip to main content
. 2018 Mar 28;17(6):7497–7504. doi: 10.3892/mmr.2018.8811

Figure 2.

Figure 2.

PL-PTX promotes ovarian cancer cell apoptosis via the caspase-dependent signal pathway. (A) PL-PTX promoted CAOV-3 ovarian cancer cell apoptosis compared with control group. (B) PL-PTX promoted caspase-3 and caspase-9 activity within CAOV-3 cells compared with control group. (C) PL-PTX treatment increased caspase-3 and caspase-9 protein expression levels within CAOV-3 cells compared with control group. (D) Inhibition of caspase-3 activity via a pan-caspase inhibitor, partially decreased PTX- and PL-PTX-induced apoptosis of CAOV-3 cells compared with in the control group. **P<0.01. PL-PTX, pegylated liposomal-paclitaxel.